ParamergeParamerge

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

National Cancer Institute (NIH)

Two-year exploratory grants for the early conceptual stages of novel cancer control ideas, including new techniques, methodologies or applications in population-based cancer research. Preliminary data are not expected.

Indicative award
up to $275k (total award)Page states combined direct costs for the two-year project period may not exceed $275,000, with no more than $200,000 in any single year. No floor published.
Timing
Several times a yearSeveral times a year · Feb, Jun, OctNo specific published date recorded. This funder publishes a cycle rather than a date, and this database does not invent one.Recurring R21 cycle beginning February 16, 2025 and continuing through 2028; expiration date September 8, 2028. The fetched page did not enumerate a single next date, so none is asserted.
Who can apply
Early-career faculty, Mid-career & senior, Any faculty rank
Eligibility
Higher education institutions, nonprofits, for-profit businesses, government entities, tribal organisations and faith-based organisations; foreign entities are eligible. Any individual with the necessary skills and institutional resources may serve as PD/PI.
SSWR clusters
Topics
exploratory research · cancer control · novel methods · behavioural science
Apply at
https://grants.nih.gov/grants/guide/pa-files/PA-25-253.html
This entry
Curated by the working group. Written 2026-08-07. The funder link has not yet been machine-checked.

Amounts and dates on this page are indicative and are maintained by people rather than scraped. Funders change ceilings, windows and eligibility without notice; confirm all details at the source above before applying.

← Back to the database